By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mast Therapeutics 

12390 El Camino Real, Suite 150

San Diego  California  92130  U.S.A.
Phone: 858-552-0866 Fax: 858-552-0876


SEARCH JOBS








Company News
Enrollment In Mast Therapeutics (MSTX)' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 4/21/2015 12:03:45 PM
Mast Therapeutics (MSTX) To Present New Data Supporting Vepoloxamer (MST-188) In Sickle Cell Disease At 9th Annual Sickle Cell Disease Research And Education Symposium And 38th National Sickle Cell Disease Scientific Meeting 4/9/2015 8:05:00 AM
Mast Therapeutics (MSTX) Reports Fourth Quarter And Full Year 2014 Financial Results 3/24/2015 10:57:27 AM
Mast Therapeutics (MSTX) To Develop Vepoloxamer (MST-188) In Chronic Heart Failure 3/23/2015 6:49:36 AM
Mast Therapeutics (MSTX) Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 3/2/2015 6:43:18 AM
Mast Therapeutics (MSTX) To Present At Cowen and Company's 35th Annual Healthcare Conference On March 2nd 2/24/2015 8:41:34 AM
Mast Therapeutics (MSTX) Announces New Data Supporting Vepoloxamer In Embolic Stroke 2/11/2015 7:59:12 AM
Mast Therapeutics (MSTX) Announces Initiation Of Phase 2a Studies Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) 2/4/2015 7:24:08 AM
Mast Therapeutics (MSTX)To Present At 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 9th 2/3/2015 11:51:18 AM
Mast Therapeutics (MSTX) Announces Management Change 1/26/2015 10:54:18 AM
12345
//-->